Need Help Persuading Your Boss to Fund Your Attendance?

Want to attend 5th GPCR-Targeted Drug Discovery Summit but need your manager’s approval?

We’ve made it easy. Use our ready-to-go approval letter to clearly outline the value of your participation and secure the green light in no time.

This is the only industry-led meeting dedicated to GPCR drug discovery, bringing together 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate next-generation therapeutics from discovery to clinic.

why-partner-tumour-new-768x512

Need More Reasons? Here Are 5 Compelling Benefits:

Harnessing AI & ML for Smarter GPCR Drug Discovery

Hear never-before-seen data, case studies, and translational insights from GPCR leaders to stay current on emerging targets, signaling mechanisms, and novel modalities

Network With Decision-Makers

Meet C-suite executives, VPs, and Directors to build collaborations, identify partners, and share solutions

Learn From 21+ Case Studies

Gain actionable insights for discovery or development programs, including deorphanisation, translational modeling, assay design, and target validation

Contribute To Scientific Discussions

Participate in curated panels, roundtables, and poster sessions to address real-world GPCR challenges and help shape the direction of the field

Access Emerging Technologies

Discover new assays, AI platforms, and structural tools accelerating GPCR discovery, and see how they can enhance your own programs

Explore The Full Event Guide

  • Explore the complete 2027 agenda, featuring a dedicated focus day deep dive into emerging discovery technologies alongside two days of cutting-edge GPCR science.
  • Preview exclusive sessions from Eli Lilly, Pfizer, Roche, Recursion Pharmaceuticals, Alphamol, and University of Miami.
  • Discover how the industry is tackling GPCR discovery's biggest challenges, from target validation and signaling biology to AI accountability and biased agonism.
  • See who you'll be networking with, including scientific decision-makers from leading pharma, biotech, and academic organizations.
  • Identify the sessions, speakers, and networking opportunities most relevant to your programs before you attend.
Brochure Cover

Attending Companies Include

Alkermes Logo
Biagon Inc. Logo
Confo Therapeutics
DrGPCR Logo
Eli Lilly
Kainova Therapeutics
Pfizer Logo
Roche Logo
explore the agenda
Explore the Agenda

Discover the latest advances in AI-enabled discovery, target validation, signaling biology, and emerging GPCR therapeutics across three days of scientific discussion.  

Join Biopharma Experts
Partner With Us

Showcase your expertise to a highly targeted audience of scientists and decision-makers actively seeking technologies, services, and partners to accelerate GPCR discovery.

Partner With Us
Join the GPCR Community

Connect with leading pharma, biotech, and academic experts tackling the biggest challenges and opportunities shaping the future of GPCR drug discovery.